These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 29754040)

  • 21. In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3).
    Presley BC; Logan BK; Jansen-Varnum SA
    J Anal Toxicol; 2020 Apr; 44(3):226-236. PubMed ID: 31665324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolic profiling of new synthetic cannabinoids, ADB-FUBIATA, AFUBIATA, CH-FUBIATA, and CH-PIATA.
    Watanabe S; Yamane H; Iwai T; Matsushita R; Seto Y
    Arch Toxicol; 2023 Dec; 97(12):3085-3094. PubMed ID: 37755504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic characteristic profiling of 1-amino-3,3-dimethyl-1-oxobutan-2-yl-derived indole and indazole synthetic cannabinoids in vitro.
    Luo X; Huang Z; Huang K; Liu X; Yang N; Luo Q
    J Pharm Biomed Anal; 2024 Nov; 250():116385. PubMed ID: 39116582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
    Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.
    Baginski SR; Rautio T; Nisbet LA; Lindbom K; Wu X; Dahlén J; McKenzie C; Gréen H
    J Anal Toxicol; 2023 Dec; 47(9):826-834. PubMed ID: 37747838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes.
    Diao X; Wohlfarth A; Pang S; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Jan; 62(1):157-69. PubMed ID: 26430074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid Identification of MDMB-CHMINACA Metabolites Using Zebrafish and Human Liver Microsomes as the Biotransformation System by LC-QE-HF-MS.
    Xu DQ; Dai Y; Zhang WF; Wang JF; Wang YY; Zhang Y; Zhao QL; Li X
    J Anal Toxicol; 2021 Jan; 44(9):1012-1026. PubMed ID: 32020177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of 4F-MDMB-BICA in zebrafish by liquid chromatography-high resolution mass spectrometry.
    Yue L; Xiang P; Shen B; Xu D; Song F; Yan H
    Drug Test Anal; 2021 Jun; 13(6):1223-1229. PubMed ID: 33629502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of the synthetic cannabinoid 5F-PY-PICA by human and rat hepatocytes and identification of biliary analytical targets by directional efflux in sandwich-cultured rat hepatocytes using UHPLC-HR-MS/MS.
    Mardal M; Annaert P; Noble C; Oorts M; Linnet K
    J Pharm Biomed Anal; 2018 Feb; 149():296-307. PubMed ID: 29128830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists.
    Norman C; Webling K; Kyslychenko O; Reid R; Krotulski AJ; Farrell R; Deventer MH; Liu H; Connolly MJ; Guillou C; Vinckier IMJ; Logan BK; NicDaéid N; McKenzie C; Stove CP; Gréen H
    Drug Test Anal; 2024 Sep; 16(9):915-935. PubMed ID: 38037247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.
    Franz F; Angerer V; Brandt SD; McLaughlin G; Kavanagh PV; Moosmann B; Auwärter V
    Drug Test Anal; 2017 Feb; 9(2):311-316. PubMed ID: 26888282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry.
    Wohlfarth A; Vikingsson S; Roman M; Andersson M; Kugelberg FC; Green H; Kronstrand R
    Forensic Sci Int; 2017 May; 274():55-63. PubMed ID: 27863836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A liquid chromatography-mass spectrometry method based on class characteristic fragmentation pathways to detect the class of indole-derivative synthetic cannabinoids in biological samples.
    Mazzarino M; de la Torre X; Botrè F
    Anal Chim Acta; 2014 Jul; 837():70-82. PubMed ID: 25000860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of ADB-FUBIATA in zebrafish and pooled human liver microsomes investigated by liquid chromatography-high-resolution mass spectrometry.
    Liu X; Tang Y; Xu L; Liu W; Xiang P; Hang T; Yan H
    Rapid Commun Mass Spectrom; 2024 May; 38(9):e9730. PubMed ID: 38456249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
    Castaneto MS; Wohlfarth A; Desrosiers NA; Hartman RL; Gorelick DA; Huestis MA
    Drug Metab Rev; 2015 May; 47(2):124-74. PubMed ID: 25853390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Metabolism and Hepatic Intrinsic Clearance of the Synthetic Cannabinoid Receptor Agonist JWH-122 and Its Four ω-Halogenated Analogues.
    Davidsen AB; Mardal M; Linnet K
    AAPS J; 2019 May; 21(4):63. PubMed ID: 31093790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
    Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
    Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.